Abstract
over 70. Mean tumor volume was 5.38 cm (0.6-143.3). Transient grade 1 or 2 acute toxicities occurred in 8% of all cases. No acute toxicities grade > 3 were identified. There were no chronic toxicities of any grade. The median followup was 18.6 months (1-65). The 1-year overall survival was 74.5 % for all patients and 78 % for primary tumors. Local control in the irradiated volume is 97 %. Conclusions: SBRT is an excellent treatment option for elderly patients with good performance status. Our encouraging results in terms of survival, local control and toxicity are in line with those reported in recent literature for younger patients.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
